Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-17T16:12:20.478Z Has data issue: false hasContentIssue false

Highly Resistant Microorganisms in a Teaching Hospital: The Role of Horizontal Spread in a Setting of Endemicity

Published online by Cambridge University Press:  02 January 2015

Ina Willemsen*
Affiliation:
Laboratory for Microbiology and Infection Control, Amphia Hospital, Breda, The Netherlands
Marlies Mooij
Affiliation:
Department of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, The Netherlands
Marsha van der Wiel
Affiliation:
Laboratory for Microbiology and Infection Control, Amphia Hospital, Breda, The Netherlands
Diana Bogaers
Affiliation:
Laboratory for Microbiology and Infection Control, Amphia Hospital, Breda, The Netherlands
Madelon van der Bijl
Affiliation:
Department of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, The Netherlands
Paul Savelkoul
Affiliation:
Department of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, The Netherlands
Jan Kluytmans
Affiliation:
Laboratory for Microbiology and Infection Control, Amphia Hospital, Breda, The Netherlands Department of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, The Netherlands
*
Laboratory for Microbiology and Infection Control, Amphia Hospital, PO Box 90158, 4800 RK Breda, The Netherlands ([email protected])

Abstract

Objective.

To determine the incidence density of highly resistant organisms (HROs) and the relative contribution of horizontal spread in a setting of endemicity.

Methods.

Prospective surveillance was performed among hospitalized patients during an 18-month period. Enterobacteriaceae, non-fermentative gram-negative bacilli, Staphylococcus aureus, Streptococcus pneumoniae, and Enterococcus faecium—all considered highly resistant, according to Dutch guidelines—were included. Epidemiological linkage and nosocomial transmission were determined on the basis of molecular typing and hospital admission data.

Results.

From 119 patients, we recovered a total of 170 unique HRO isolates, as follows: Escherichia coli, 96 isolates; Klebsiella species, 11 isolates; Enterobacter species, 8 isolates; Proteus species, 9 isolates; Citrobacter species, 5 isolates; Pseudomonas species, 5 isolates; Aci-netobacter species, 3 isolates; Morganella species, 2 isolates; Salmonella species, 1 isolate; Serratia species, 1 isolate; S. pneumoniae, 20 isolates; and S. aureus, 9 isolates. No vancomycin-resistant E. faecium was found. The incidence density was 4.3 HRO isolates per 10,000 patient-days. The majority of HRO isolates were unique, and nosocomial transmission was observed 4 times for highly resistant gram-negative bacilli (case reproduction rate, 0.05) and 4 times for penicillin-nonsusceptible S. pneumoniae (case reproduction rate, 0.29). A stay on the intensive care unit was the main determinant for the recovery of an HRO.

Conclusion.

Nosocomial transmission of HROs was observed 8 times during the 18-month period. The intensive care unit was identified as the main reservoir of horizontal spread of HROs. This study shows that nosocomial transmission of HROs is largely preventable using transmission precautions.

Type
Original Articles
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Austin, DJ, Kristinsson, KG, Anderson, RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc Natl Acad Sci USA 1999;96:11521156.Google Scholar
2. Paterson, DL. The role of antimicrobial management programs in optimizing antibiotic prescribing within hospitals. Clin Infect Dis 2006;42(Supp 2):S90S95.Google Scholar
3. Savelkoul, PHM, Aarts, HJ, de Haas, J, et al. Amplified-fragment length polymorphism analysis: the state of an art. J Clin Microbiol 1999;37:30833091.Google Scholar
4. Strausbaugh, LJ, Siegel, JD, Weinstein, RA. Preventing transmission of multidrug-resistant bacteria in health care settings: a tale of 2 guidelines. Clin Infect Dis 2006;42:828835.Google Scholar
5. Struelens, MJ. The epidemiology of antimicrobial resistance in hospital acquired infections: problems and possible solutions. BMJ 1998;317:652654.Google Scholar
6. Kluytmans-VandenBergh, MFQ, Kluytmans, JAJW, Voss, A. Dutch guideline for preventing nosocomial transmission of highly resistant microorganisms (HRMO). Infection 2005;33:309313.Google Scholar
7. Werkgroep Infectie Preventie. Policy for highly resistant microorganisms. Available at: http://www.wip.nl. Posted May 8, 2007. Accessed October 2008.Google Scholar
8. Vandenbroucke-Grauls, CM. Methicillin-resistant Staphylococcus aureus control in hospitals: the Dutch experience. Infect Control Hosp Epidemiol 1996;17:512513.Google Scholar
9. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing: 15th information supplement. Wayne, PA: CLSI; 2005:M100SI5.Google Scholar
10. Werkgroep Infectie Preventie. Policy for MRSA in hospitals. Available at: http://www.wip.nl. Posted February 27, 2007. Accessed October 2008.Google Scholar
11. Van der Zwet, WC, Debets-Ossenkopp, YJ, Reinders, E, et al. Nosocomial spread of a Staphylococcus capitis strain with heteroresistance to vancomycin in a neonatal intensive care unit. J Clin Microbiol 2002;40:25202525.Google Scholar
12. Pitout, JD, Laupland, KB. Extended-spectrum beta-lactamase producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008;8:159166.Google Scholar
13. National Nosocomial Infections Surveillance System (NNIS). NNIS System Report: data summary from January 1992 through June 2004, issued October. Am J Infect Control 2004;32:470485.Google Scholar
14. Vonberg, RP, Wolter, A, Chaberny, IF, et al. Epidemiology of multi-drug-resistant gram-negative bacteria: data from an university hospital over a 36-month period. Int J Hyg Environ Health 2008;211:251257.Google Scholar
15. Koeleman, JG, Stoof, J, Biesmans, DJ, Savelkoul, PHM, Vandenbroucke-Grauls, CMJE. Comparison of amplified ribosomal DNA restriction analysis, random amplified polymorphic DNA analysis, and amplified fragment length polymorphism fingerprinting for identification of Acinetobacter genomic species and typing of Acinetobacter baumannii . J Clin Microbiol 1998;36:25222529.Google Scholar
16. Grundman, H, Bärwolff, S, Tami, A, et al. How many infections are caused by patient-to-patient transmission in intensive care units? Crif Care Med 2005;33:946951.Google Scholar
17. Levesque, C, Piche, L, Larose, C, Roy, PH. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother 1995;39:185191.Google Scholar
18. Klugman, KP. Pneumococcol resistance to antibiotics. Clin Microbiol Rev 1990;3:171196.Google Scholar
19. Vos, MC, Ott, A, Verburgh, HA. Successful search-and-destroy policy for methicillin-resistant Staphylococcus aureus in The Netherlands. J Clin Microbiol 2005;43:2034.CrossRefGoogle ScholarPubMed
20. Wannet, WJ, Spalburg, E, Heck, ME, Pluister, GN, Willems, RJL, de Neeling, AJ. Widespread dissemination in the Netherlands of the epidemic Berlin methicillin-resistant Staphylococcus aureus clone with low-level resistance to oxacillin. J Clin Microbiol 2004;42:30773082.Google Scholar
21. Endtz, HP, van den Braak, N, van Belkum, A, et al. Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The Netherlands. J Clin Microbiol 1997;35:30263031.Google Scholar
22. Van den Braak, N, Ott, A, van Belkum, A, et al. Prevalence and determinants of fecal colonization with vancomycin-resistant Enterococcus in hospitalized patients in the Netherlands. Infect Control Hosp Epidemiol 2000;21:520524.Google Scholar
23. Thouverez, M, Talon, D, Bertrand, X. Control of Enterobacteriaceae producing extended-spectrum beta-lactamase in intensive care units: rectal screening may not be needed in non-epidemic situations. Infect Control Hosp Epidemiol 2004;25:838841.Google Scholar
24. Reddy, P, Malczynski, M, Obias, A, et al. Screening for extended spectrum beta-lactamase producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia. Clin Infect Dis 2007;45:846852.Google Scholar